List of Osiris Therapeutics patents

Patents where

Current Assignee

Name

Osiris Therapeutics

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11318168 Human tissue derived compositions and uses thereof		Osiris Therapeutics	Osiris Therapeutics	United States Patent and Trademark Office	11318168	May 3, 2022
‌ US Patent 11464809 Umbilical tissue compositions and methods of use	Patent 11464809 was granted and assigned to Osiris Therapeutics on October, 2022 by the United States Patent and Trademark Office.	Osiris Therapeutics	Osiris Therapeutics	United States Patent and Trademark Office	11464809	October 11, 2022
‌ US Patent 11638725 Methods of manufacture of immunocompatible chorionic membrane products	Patent 11638725 was granted and assigned to Osiris Therapeutics on May, 2023 by the United States Patent and Trademark Office.	Osiris Therapeutics	Osiris Therapeutics	United States Patent and Trademark Office	11638725	May 2, 2023
‌ US Patent 10272116 Immunocompatible amniotic membrane products	Patent 10272116 was granted and assigned to Osiris Therapeutics on April, 2019 by the United States Patent and Trademark Office.	Osiris Therapeutics	Osiris Therapeutics	United States Patent and Trademark Office	10272116	April 30, 2019
‌ US Patent 7892829 Cardiac muscle regeneration using mesenchymal stem cells	Patent 7892829 was granted and assigned to Osiris Therapeutics on February, 2011 by the United States Patent and Trademark Office.		Osiris Therapeutics	United States Patent and Trademark Office	7892829	February 22, 2011
‌ US Patent 9956248 Methods of manufacture of therapeutic products comprising vitalized placental dispersions	Patent 9956248 was granted and assigned to Osiris Therapeutics on May, 2018 by the United States Patent and Trademark Office.	Osiris Therapeutics	Osiris Therapeutics	United States Patent and Trademark Office	9956248	May 1, 2018
‌ US Patent 11590173 Methods of manufacture of therapeutic products comprising vitalized placental dispersions		Osiris Therapeutics	Osiris Therapeutics	United States Patent and Trademark Office	11590173	February 28, 2023
‌ US Patent 11510947 Methods of manufacture of immunocompatible amniotic membrane products	Patent 11510947 was granted and assigned to Osiris Therapeutics on November, 2022 by the United States Patent and Trademark Office.	Osiris Therapeutics	Osiris Therapeutics	United States Patent and Trademark Office	11510947	November 29, 2022
‌ US Patent 11406735 Methods of manufacturing cartilage products	Patent 11406735 was granted and assigned to Osiris Therapeutics on August, 2022 by the United States Patent and Trademark Office.	Osiris Therapeutics	Osiris Therapeutics	United States Patent and Trademark Office	11406735	August 9, 2022
‌ US Patent 11590172 Immunocompatible chorionic membrane products		Osiris Therapeutics	Osiris Therapeutics	United States Patent and Trademark Office	11590172	February 28, 2023
‌ US Patent 11413373 Disrupted cartilage products	Patent 11413373 was granted and assigned to Osiris Therapeutics on August, 2022 by the United States Patent and Trademark Office.	Osiris Therapeutics	Osiris Therapeutics	United States Patent and Trademark Office	11413373	August 16, 2022
‌ US Patent 10265344 Immunocompatible chorionic membrane products	Patent 10265344 was granted and assigned to Osiris Therapeutics on April, 2019 by the United States Patent and Trademark Office.	Osiris Therapeutics	Osiris Therapeutics	United States Patent and Trademark Office	10265344	April 23, 2019
‌ US Patent 10994913 Support and packaging for membranes	Patent 10994913 was granted and assigned to Osiris Therapeutics on May, 2021 by the United States Patent and Trademark Office.	Osiris Therapeutics	Osiris Therapeutics	United States Patent and Trademark Office	10994913	May 4, 2021
‌ US Patent 11207353 Immunocompatible amniotic membrane products	Patent 11207353 was granted and assigned to Osiris Therapeutics on December, 2021 by the United States Patent and Trademark Office.	Osiris Therapeutics	Osiris Therapeutics	United States Patent and Trademark Office	11207353	December 28, 2021
‌ US Patent 8017157 Method of treating a wound with acidified plasma or serum	Patent 8017157 was granted and assigned to Osiris Therapeutics on September, 2011 by the United States Patent and Trademark Office.		Osiris Therapeutics	United States Patent and Trademark Office	8017157	September 13, 2011
‌ US Patent 10646519 Methods of manufacture of therapeutic products comprising vitalized placental dispersions		Osiris Therapeutics	Osiris Therapeutics	United States Patent and Trademark Office	10646519	May 12, 2020
‌ US Patent 10258650 Methods of manufacture of immunocompatible chorionic membrane products	Patent 10258650 was granted and assigned to Osiris Therapeutics on April, 2019 by the United States Patent and Trademark Office.	Osiris Therapeutics	Osiris Therapeutics	United States Patent and Trademark Office	10258650	April 16, 2019
‌ US Patent 10828395 Bone repair product and methods of use thereof		Osiris Therapeutics	Osiris Therapeutics	United States Patent and Trademark Office	10828395	November 10, 2020
‌ US Patent 10729809 Bone repair product and methods of use thereof		Osiris Therapeutics	Osiris Therapeutics	United States Patent and Trademark Office	10729809	August 4, 2020
‌ US Patent 10874763 Porated cartilage products	Patent 10874763 was granted and assigned to Osiris Therapeutics on December, 2020 by the United States Patent and Trademark Office.	Osiris Therapeutics	Osiris Therapeutics	United States Patent and Trademark Office	10874763	December 29, 2020
‌ US Patent 10624931 Umbilical tissue compositions and methods of use		Osiris Therapeutics	Osiris Therapeutics	United States Patent and Trademark Office	10624931	April 21, 2020
‌ US Patent 10603174 Compositions comprising meniscal tissues and uses thereof		Osiris Therapeutics	Osiris Therapeutics	United States Patent and Trademark Office	10603174	March 31, 2020
‌ US Patent 12109241 Methods of manufacture of immunocompatible chorionic membrane products	Patent 12109241 was granted and assigned to Osiris Therapeutics on October, 2024 by the United States Patent and Trademark Office.	Osiris Therapeutics	Osiris Therapeutics	United States Patent and Trademark Office	12109241	October 8, 2024
‌ US Patent 11986498 Therapeutic products comprising vitalized placental dispersions	Patent 11986498 was granted and assigned to Osiris Therapeutics on May, 2024 by the United States Patent and Trademark Office.	Osiris Therapeutics	Osiris Therapeutics	United States Patent and Trademark Office	11986498	May 21, 2024

24 results

0 selected

24 results

0 selected